scholarly journals Mortality Among People With HIV Treated for Tuberculosis Based on Positive, Negative, or No Bacteriologic Test Results for Tuberculosis: The IeDEA Consortium

2020 ◽  
Vol 7 (1) ◽  
Author(s):  
John M Humphrey ◽  
Philani Mpofu ◽  
April C Pettit ◽  
Beverly Musick ◽  
E Jane Carter ◽  
...  
Keyword(s):  
Treatment Initiation ◽  
Proportional Hazard ◽  
Test Results ◽  
Risk Of Death ◽  
Tb Treatment ◽  
Cox Proportional Hazard ◽  
Observational Cohort ◽  
Facility Level ◽  
International Epidemiology ◽  
Lower Hazard

Abstract Background In resource-constrained settings, many people with HIV (PWH) are treated for tuberculosis (TB) without bacteriologic testing. Their mortality compared with those with bacteriologic testing is uncertain. Methods We conducted an observational cohort study among PWH ≥15 years of age initiating TB treatment at sites affiliated with 4 International epidemiology Databases to Evaluate AIDS consortium regions from 2012 to 2014: Caribbean, Central and South America, and Central, East, and West Africa. The exposure of interest was the TB bacteriologic test status at TB treatment initiation: positive, negative, or no test result. The hazard of death in the 12 months after TB treatment initiation was estimated using a Cox proportional hazard model. Missing covariate values were multiply imputed. Results In 2091 PWH, median age 36 years, 53% had CD4 counts ≤200 cells/mm3, and 52% were on antiretroviral therapy (ART) at TB treatment initiation. The adjusted hazard of death was higher in patients with no test compared with those with positive test results (hazard ratio [HR], 1.56; 95% confidence interval [CI], 1.08–2.26). The hazard of death was also higher among those with negative compared with positive tests but was not statistically significant (HR, 1.28; 95% CI, 0.91–1.81). Being on ART, having a higher CD4 count, and tertiary facility level were associated with a lower hazard for death. Conclusions There was some evidence that PWH treated for TB with no bacteriologic test results were at higher risk of death than those with positive tests. Research is needed to understand the causes of death in PWH treated for TB without bacteriologic testing.

scholarly journals Mortality among adults living with HIV treated for tuberculosis based on positive, negative, or no bacteriologic test results for tuberculosis: the IeDEA consortium

2019 ◽  
Author(s):  
John M Humphrey ◽  
Philani Mpofu ◽  
April C. Pettit ◽  
Beverly Musick ◽  
E. Jane Carter ◽  
...  
Keyword(s):  
West Africa ◽  
Treatment Initiation ◽  
People Living With Hiv ◽  
Test Results ◽  
Resource Constrained ◽  
Tb Treatment ◽  
Cox Proportional Hazard ◽  
Observational Cohort ◽  
Facility Level ◽  
Living With Hiv

AbstractBackgroundIn resource-constrained settings, people living with HIV (PLWH) treated for tuberculosis (TB) despite negative bacteriologic tests have a higher mortality than those treated with positive tests. Many PLWH are treated without bacteriologic testing; their mortality compared to those with bacteriologic testing is uncertain.MethodsWe conducted an observational cohort study among PLWH ≥ 15 years of age who initiated TB treatment at clinical sites affiliated with four regions of the International epidemiology Databases to Evaluate AIDS (IeDEA) consortium from 2012-2014: Caribbean, Central and South America, and Central, East, and West Africa. The primary exposure of interest was the TB bacteriologic test status at TB treatment initiation: positive, negative, or no test result. The hazard for death in the 12 months following TB treatment initiation was estimated using the Cox proportional hazard model, adjusted for patient- and site-level factors. Missing covariates were multiply imputed.ResultsAmong 2,091 PLWH included, the median age at TB treatment initiation was 36 years, 44% were female, 53% had CD4 counts ≤ 200 cells/mm3, and 52% were on antiretroviral treatment (ART). Compared to patients with positive bacteriologic tests, the adjusted hazard for death was higher among patients with no test results (HR 1.56, 95% CI 1.08-2.26) but not different than those with negative tests (HR 1.28, 95% CI 0.91-1.81). Older age was also associated with a higher hazard for death, while being on ART, having a higher CD4 count, West Africa region, and tertiary facility level were associated with lower hazards for death.ConclusionPLWH treated for TB with no bacteriologic test results were more likely to die than those treated with positive tests, underscoring the importance of TB bacteriologic diagnosis in resource-constrained settings. Research is needed to understand the causes of death among PLWH treated for TB in the absence of positive bacteriologic tests.

Association of Dementia-Related Psychosis With Long-term Care Use and Death

Neurology ◽  
2021 ◽  
Vol 96 (12) ◽  
pp. e1620-e1631
Author(s):  
James B. Wetmore ◽  
Yi Peng ◽  
Heng Yan ◽  
Suying Li ◽  
Muna Irfan ◽  
...  
Keyword(s):  
Long Term Care ◽  
Fold Increase ◽  
Proportional Hazard ◽  
Comorbid Conditions ◽  
Term Care ◽  
Risk Of Death ◽  
Cox Proportional Hazard ◽  
Increased Risk ◽  
Cox Proportional Hazard Regression

ObjectiveTo determine the association of dementia-related psychosis (DRP) with death and use of long-term care (LTC); we hypothesized that DRP would be associated with increased risk of death and use of LTC in patients with dementia.MethodsA retrospective cohort study was performed. Medicare claims from 2008 to 2016 were used to define cohorts of patients with dementia and DRP. Outcomes were LTC, defined as nursing home stays of >100 consecutive days, and death. Patients with DRP were directly matched to patients with dementia without psychosis by age, sex, race, number of comorbid conditions, and dementia index year. Association of DRP with outcomes was evaluated using a Cox proportional hazard regression model.ResultsWe identified 256,408 patients with dementia. Within 2 years after the dementia index date, 13.9% of patients developed DRP and 31.9% had died. Corresponding estimates at 5 years were 25.5% and 64.0%. Mean age differed little between those who developed DRP (83.8 ± 7.9 years) and those who did not (83.1 ± 8.7 years). Patients with DRP were slightly more likely to be female (71.0% vs 68.3%) and white (85.7% vs 82.0%). Within 2 years of developing DRP, 16.1% entered LTC and 52.0% died; corresponding percentages for patients without DRP were 8.4% and 30.0%, respectively. In the matched cohort, DRP was associated with greater risk of LTC (hazard ratio [HR] 2.36, 2.29–2.44) and death (HR 2.06, 2.02–2.10).ConclusionsDRP was associated with a more than doubling in the risk of death and a nearly 2.5-fold increase in risk of the need for LTC.

Significance of Platelet and AFP Levels and Liver Function Parameters for HCC Size and Survival

2014 ◽  
Vol 29 (3) ◽  
pp. 215-223 ◽  
Author(s):  
Brian I. Carr ◽  
Vito Guerra ◽  
Edoardo G. Giannini ◽  
Fabio Farinati ◽  
Francesca Ciccarese ◽  
...  
Keyword(s):  
Tumor Size ◽  
Blood Platelet ◽  
Tumor Diameter ◽  
Proportional Hazard ◽  
Gamma Glutamyl Transpeptidase ◽  
Vein Thrombosis ◽  
Risk Of Death ◽  
Cox Proportional Hazard ◽  
Maximum Tumor Diameter ◽  
Glutamyl Transpeptidase

Background Hepatocellular carcinoma (HCC) is a heterogeneous disease with both tumor and liver factors being involved. Aims To investigate HCC clinical phenotypes and factors related to HCC size. Methods Prospectively-collected HCC patients' data from a large Italian database were arranged according to the maximum tumor diameter (MTD) and divided into tumor size terciles, which were then compared in terms of several common clinical parameters and patients' survival. Results An higer MTD tercile was significantly associated with increased blood alpha-fetoprotein (AFP), gamma-glutamyl transpeptidase (GGTP), and platelet levels. Patients with higher platelet levels had larger tumors and higher GGTP levels, with lower bilirubin levels. However, patients with the highest AFP levels had larger tumors and higher bilirubin levels, reflecting an aggressive biology. AFP correlation analysis revealed the existence of 2 different groups of patients: those with higher and with lower AFP levels, each with different patient and tumor characteristics. The Cox proportional-hazard model showed that a higher risk of death was correlated with GGTP and bilirubin levels, tumor size and number, and portal vein thrombosis (PVT), but not with AFP or platelet levels. Conclusions An increased tumor size was associated with increased blood platelet counts, AFP and GGTP levels. Platelet and AFP levels were important indicators of tumor size, but not of survival.

Mortality among seafarers: a register-based follow-up study

2020 ◽  
Vol 70 (2) ◽  
pp. 119-122 ◽  
Author(s):  
H Rinne ◽  
M Laaksonen ◽  
V Notkola ◽  
R Shemeikka
Keyword(s):  
Causes Of Death ◽  
Sociodemographic Factors ◽  
Proportional Hazard ◽  
Proportional Hazard Model ◽  
Occupational Risk Factors ◽  
Risk Of Death ◽  
Cox Proportional Hazard ◽  
Changing Practices ◽  
Healthy Behaviour

Abstract Background Seafarers are exposed to many occupational risk factors. Aims To study whether there are differences in mortality between seafarers and other employees, whether there are variations in seafarers’ mortality between different seafaring occupations and whether these differences can be explained by sociodemographic factors. Methods A register-based study of all seafarers aged 25–64 years, resident in Finland in 2000 with minimum 5 years of cumulative seafaring experience on Finnish vessels and other employees, followed for mortality 2001–13. Analysis methods included age standardized death rates, mortality ratios (SMR) and Cox proportional hazard model. Results During the follow-up period 2001–13, there were 81,035 person years and 382 deaths in the cohort of seafarers. Seafarers had 1.3 times higher risk of death (men SMR 132, 95% confidence intervals [CI] 118–147, women SMR 125, 95% CI 99–157) than other employees. Mortality was especially high in alcohol-related causes (men SMR 172, 95% CI 126–233, women SMR 262, 95% CI 131–525) and causes related to smoking. Controlling for sociodemographic characters strengthened the risk compared to other occupations. Mortality was high among male deck and engine crew and among male and female galley personnel. The mortality differences between different seafaring occupations were partly explained by adjustments of sociodemographic characters. Conclusions Seafarers still have increased mortality among men after adjustment of sociodemographic characters. Results by causes of death suggest that changing practices to enable healthy behaviour are important.

scholarly journals Prevalence and outcome of dysnatremia in patients with COVID-19 compared to controls

2021 ◽  
Vol 184 (3) ◽  
pp. 413-422
Author(s):  
Cihan Atila ◽  
Clara O Sailer ◽  
Stefano Bassetti ◽  
Sarah Tschudin-Sutter ◽  
Roland Bingisser ◽  
...  
Keyword(s):  
Clinical Laboratory ◽  
Predictive Marker ◽  
Nasopharyngeal Swab ◽  
Prognostic Impact ◽  
Proportional Hazard ◽  
Primary Analysis ◽  
Cox Proportional Hazard ◽  
Appropriate Treatment ◽  
Treatment Measures ◽  
Observational Cohort

Objective The pandemic of coronavirus disease (COVID-19) has rapidly spread globally and infected millions of people. The prevalence and prognostic impact of dysnatremia in COVID-19 is inconclusive. Therefore, we investigated the prevalence and outcome of dysnatremia in COVID-19. Design The prospective, observational, cohort study included consecutive patients with clinical suspicion of COVID-19 triaged to a Swiss Emergency Department between March and July 2020. Methods Collected data included clinical, laboratory and disease severity scoring parameters on admission. COVID-19 cases were identified based on a positive nasopharyngeal swab test for SARS-CoV-2, patients with a negative swab test served as controls. The primary analysis was to assess the prognostic impact of dysnatremia on 30-day mortality using a cox proportional hazard model. Results 172 (17%) cases with COVID-19 and 849 (83%) controls were included. Patients with COVID-19 showed a higher prevalence of hyponatremia compared to controls (28.1% vs 17.5%, P < 0.001); while comparable for hypernatremia (2.9% vs 2.1%, P = 0.34). In COVID-19 but not in controls, hyponatremia was associated with a higher 30-day mortality (HR: 1.4, 95% CI: 1.10–16.62, P = 0.05). In both groups, hypernatremia on admission was associated with higher 30-day mortality (COVID-19 - HR: 11.5, 95% CI: 5.00–26.43, P < 0.001; controls - HR: 5.3, 95% CI: 1.60–17.64, P = 0.006). In both groups, hyponatremia and hypernatremia were significantly associated with adverse outcome, for example, intensive care unit admission, longer hospitalization and mechanical ventilation. Conclusion Our results underline the importance of dysnatremia as predictive marker in COVID-19. Treating physicians should be aware of appropriate treatment measures to be taken for patients with COVID-19 and dysnatremia.

scholarly journals 2192 The association of preoperative functional capacity and outcomes for head and neck cancer patients undergoing definitive surgical treatment

2018 ◽  
Vol 2 (S1) ◽  
pp. 88-88
Author(s):  
Sampat Sindhar ◽  
Dorina Kallogjeri ◽  
Troy S. Wildes ◽  
Michael S. Avidan ◽  
Jay Piccirillo
Keyword(s):  
Overall Survival ◽  
Surgical Treatment ◽  
Head And Neck ◽  
Functional Capacity ◽  
Cancer Center ◽  
Proportional Hazard ◽  
Risk Of Death ◽  
Metabolic Equivalents ◽  
Cox Proportional Hazard ◽  
Patient Reported

OBJECTIVES/SPECIFIC AIMS: To study the role functional capacity plays in surgical outcomes for head and neck cancers. METHODS/STUDY POPULATION: In this single-institution cohort study, we combined preoperative anesthesia assessment information with oncology registry data for newly-diagnosed patients with squamous cell carcinoma of the oral cavity, pharynx, and larynx (HNSCC) treated with definitive surgery at Siteman Cancer Center from 2012 to 2016. Patient-reported exercise capacity was assessed as metabolic equivalents. Metabolic equivalents<4 was defined as poor functional capacity. The primary outcome measure was overall survival (OS). Kaplan-Meir survival analysis was used to compare the survival of patients with poor functional capacity (PFC) and patients with normal functional capacity (NFC). Cox proportional hazard regression was used to explore the independent prognostic role of functional capacity on overall survival after controlling for other factors. RESULTS/ANTICIPATED RESULTS: A total of 671 patients underwent surgical treatment for HNSCC. The average age was 62 years (range: 19–94 years). Majority of the patients were male (n=481; 72%), White race (n=589; 88%), and smokers (n=528; 79%). Of 671 patients, 22% (n=146) had PFC. Two-year OS rate in PFC patients was 70% compared with 85% in NFC patients (15% difference; 95% CI: 7%–23%). Unadjusted Cox proportional hazard analysis showed that PFC patients had 2.2 times higher risk of death (95% CI: 1.5–3.2) than NFC patients. After adjustment for age at surgery, BMI, preoperative weight loss, comorbidity score, tumor site, and TNM stage the magnitude of the association between functional capacity and OS decreased (aHR=1.3; 95% CI: 0.88–1.98). DISCUSSION/SIGNIFICANCE OF IMPACT: Poor functional capacity is associated with decreased overall survival, but the magnitude of the association, while clinically meaningful, decreases after controlling for other important patient and tumor factors. Nevertheless, we believe preoperative functional capacity status is an important patient factor to consider when discussing prognosis and attempting risk stratification. We also believe that functional capacity may be associated with 30-day unplanned readmissions and 90-day complications and are currently performing chart review to ascertain this information.

scholarly journals Platelet Count Trajectory and Mortality in Septic Shock: A Retrospective Cohort Study

Blood ◽  
2020 ◽  
Vol 136 (Supplement 1) ◽  
pp. 16-16
Author(s):  
Neelan Sriranjan ◽  
Brett L. Houston ◽  
Emily Rimmer ◽  
Chantalle Menard ◽  
Murdoch Leeies ◽  
...  
Keyword(s):  
Septic Shock ◽  
Platelet Count ◽  
Retrospective Cohort ◽  
Trajectory Analysis ◽  
Cox Proportional Hazard Model ◽  
Proportional Hazard ◽  
Proportional Hazard Model ◽  
Risk Of Death ◽  
Cox Proportional Hazard ◽  
Organ Failures

Background: In Canada, septic shock accounts for approximately 30,000 hospitalizations annually and is associated with a mortality rate of 30%. Thrombocytopenia in septic shock is associated with a poor prognosis including increased length of stay, longer duration of organ support, increased major bleeding events and mortality. The trajectory of the platelet count over time in patients with septic shock has not been well-studied. We hypothesized that the platelet count trajectory in septic shock can identify distinct clinical groups and is an independent predictor of 30-day mortality. Objectives: 1) To identify groups of patients with distinct platelet count trajectories; 2) To evaluate patient and illness factors associated with platelet count trajectories; and 3) To estimate the association of platelet count trajectory with mortality patients with septic shock. Methods: We performed a retrospective cohort study of adult patients admitted with septic shock to an intensive care unit (ICU) in Winnipeg, Canada between 2006-2014. We used group-based trajectory analysis to analyze the trend of platelet count over the first seven days of ICU admission to group patients with similar platelet trajectories. Group-based trajectory analysis is a statistical method that analyzes the pattern of a variable over time and allows distinct groups with similar trajectories to arise from the data. We utilized both the Bayesian Information Criterion (BIC) and clinical validity characteristics to choose the most suitable trajectory model. We developed a multinomial logistic regression model to associate patient characteristics with platelet count trajectories. We created a multivariable Cox proportional hazard model adjusted for age, sex, Acute Physiology and Chronic Health Evaluation (APACHE) II score, comorbidities, site or source of infection, and time to first appropriate antimicrobial to examine the association between platelet count trajectory and 30-day mortality. Results: Our study cohort included 913 patients with septic shock. The favoured trajectory model identified six distinct trajectories (Figure 1) using the platelet count over the first 7 days of ICU admission. We found that the number of organ failures on day 1was independently associated with platelet count trajectory, while other characteristics were not. The 30-day mortality of the entire cohort was 26.2% and ranged from 16.4% in group 1 (rising platelet count) to 44.4% in group 6 (high platelet count throughout). In the multivariable Cox proportional hazard model, compared with group 2 (thrombocytopenia), group 4 (high normal platelet count) was independently associated with a reduced risk of death at 30 days (Hazard Ratio (HR) 0.33, p = 0.002). The trajectory group with thrombocytosis (group 6) was associated with an increased risk of death at 30 days (HR 3.24, p=0.48) however the small number in this group limits the generalizability of this finding. Conclusion: We identified 6 distinct and clinically relevant platelet count trajectories in critically ill patients with septic shock. Platelet count trajectory was associated with the number of organ failures on day 1. Our study confirms that thrombocytopenia is associated with a worse prognosis as other trajectories with higher platelet count were associated with a lower risk of death. While it is well recognized that thrombocytopenia is associated with adverse outcomes in patients with septic shock, it is not known whether other patterns of the platelet trajectory such as thrombocytosis are similarly clinically important. Further studies are needed to fully characterize the impact platelet count trajectory on outcomes in patients with septic shock. The interplay between platelet count trajectory and other parameters (such as the white blood cell count trajectory, or INR trajectory) may have a more predictive role in evaluating prognosis in sepsis. Disclosures No relevant conflicts of interest to declare.

scholarly journals Comparison of the clinical characteristics and mortality in ARDS due to COVID-19 versus ARDS due to Influenza A-H1N1pdm09

2021 ◽  
Author(s):  
Carmen Hernández Cárdenas ◽  
Gustavo Lugo ◽  
Diana Hernández García ◽  
Rogelio Pérez-Padilla
Keyword(s):  
Intensive Care Unit ◽  
Intensive Care ◽  
Sofa Score ◽  
Influenza A ◽  
Proportional Hazard ◽  
Proportional Hazard Model ◽  
Risk Of Death ◽  
Cox Proportional Hazard ◽  
Influenza A H1n1 ◽  
Failure Assessment

AbstractImportanceInfection with the SARS-Cov-2 and Influenza A-H1N1 viruses is responsible for the first pandemics of the 21st century. Both of these viruses can cause severe pneumonia and acute respiratory distress syndrome (ARDS). The clinical differences and mortality associated with these two pandemic pneumonias in patients with ARDS are not well establishedObjectiveTo compare case-fatality between ARDS-Covid-19 and ARDS-Influenza A (H1N1), adjusting for known prognostic risk factors.Design, Setting and ParticipantsOne hundred forty-seven patients with COVID-19 were compared with 94 with Influenza A-H1N1, all of these were admitted to the intensive care unit of the Referral Center for Respiratory Diseases and COVID-19 in Mexico City and fulfilled the criteria of ARDS.ResultsPatients arrived at the hospital after 9 days of symptoms. Influenza patients had more obesity, more use of Norepinephrine, and higher levels of lactic dehydrogenase and glucose, and fewer platelets and lower PaO2/FIO2. Crude mortality was higher in COVID than in influenza (39% vs. 22%; p = 0.005). In a Cox proportional hazard model, patients with a diagnosis of COVID-19 had a hazard ratio (HR) = 3.7; 95% Confidence Interval [CI] = 1.9-7.4, adjusted for age, gender, sequential organ failure assessment (SOFA) score, ventilatory ratio, and prone ventilation. In the fully adjusted model, the ventilatory ratio and the absence of prone-position ventilation were also predictors of mortality.CONCLUSIONCOVID-19 patients treated in an intensive care unit (ICU) had a 3.7 times higher risk of death than similar patients with Influenza A-H1N1, after adjusting for SOFA score and other relevant risk factors for mortality.QuestionIs the mortality of ARDS associated with Covid-19 greater than that of ARDS associated to influenza H1N1?FindingsIn a Cox proportional hazard model, patients with a diagnosis of COVID-19 had a hazard ratio (HR) = 3.7; 95% Confidence Interval [CI] = 1.9-7.4, adjusted for age, gender, sequential organ failure assessment (SOFA) score.MeaningCOVID-19 patients treated in an intensive care unit (ICU) had a 3.7 times higher risk of death than similar patients with Influenza A-H1N1

OS10.8.A The effectiveness of antiepileptic drug duotherapies in glioma patients: a multicenter observational cohort study

2021 ◽  
Vol 23 (Supplement_2) ◽  
pp. ii14-ii14
Author(s):  
P B van der Meer ◽  
L Dirven ◽  
M Fiocco ◽  
M Vos ◽  
M C M Kouwenhoven ◽  
...  
Keyword(s):  
Cohort Study ◽  
Adverse Effects ◽  
Treatment Failure ◽  
Antiepileptic Drug ◽  
Observational Cohort Study ◽  
Proportional Hazard ◽  
Cox Proportional Hazard ◽  
Cox Proportional Hazard Models ◽  
Observational Cohort

Abstract BACKGROUND About 30% of glioma patients need an add-on antiepileptic drug (AED) due to uncontrolled seizures on AED monotherapy. This study aimed to determine whether levetiracetam combined with valproic acid (LEV+VPA), a commonly prescribed duotherapy, is more effective than other duotherapy combinations including either LEV or VPA in glioma patients. MATERIAL AND METHODS In this multicenter retrospective observational cohort study, treatment failure (i.e. replacement by or addition of a new AED, or withdrawal of an AED) for any reason was the primary outcome. Secondary outcomes included: 1) treatment failure due to uncontrolled seizures; and 2) treatment failure due to adverse effects. Time to treatment failure was defined as the time from the start of AED duotherapy until the time of treatment failure. Multivariable Cox proportional hazard models were estimated to study the association between risk factors and treatment failure. The maximum duration of follow-up was 36 months. RESULTS A total of 1435 patients were treated with first-line monotherapy LEV or VPA, of which 355 patients received AED duotherapy after they had treatment failure due to uncontrolled seizures on monotherapy. LEV+VPA was prescribed in 66% (236/355) and other AED duotherapy combinations including LEV or VPA in 34% (119/355) of patients. Patients using other duotherapy versus LEV+VPA had higher risk of treatment failure for any reason (cause-specific hazard ratio [csHR]=1.50 [95%CI=1.07–2.12], p=0.020), treatment failure due to uncontrolled seizures (csHR=1.73 [95%CI=1.10–2.73], p=0.018). There were no differences in failure due to adverse effects (csHR=0.88 [95%CI=0.47–1.67]), p=0.703) between the two groups. CONCLUSION This observational cohort study suggests that LEV+VPA has better efficacy than other AED combinations. Similar toxicities were experienced in the two groups.

scholarly journals Treatment outcomes of initial differential antiretroviral regimens among HIV patients in Southwest China: comparison from an observational cohort study

BMJ Open ◽  
2019 ◽  
Vol 9 (3) ◽  
pp. e025666 ◽  
Author(s):  
Ruihua Kang ◽  
Liuhong Luo ◽  
Huanhuan Chen ◽  
Qiuying Zhu ◽  
Lingjie Liao ◽  
...  
Keyword(s):  
Cohort Study ◽  
Treatment Outcomes ◽  
Attrition Rate ◽  
Proportional Hazard ◽  
Hiv Patients ◽  
Cox Proportional Hazard ◽  
Real World Setting ◽  
Cox Proportional Hazard Models ◽  
Observational Cohort ◽  
Better Than

ObjectivesChina has continued to expand antiretroviral therapy (ART) services and optimise ART guidelines in an effort to significantly reduce and prevent mortality and transmission rates among HIV patients. However, no study to date has compared treatment outcomes of initial differential antiretroviral regimens among HIV patients in a real-world setting in China. This study aimed to compare the effects of different ART regimens on treatment outcomes among adults.DesignObservational retrospective cohort study.SettingData from 2011 to 2013 in Guangxi, China.ParticipantsPatients aged ≥18 years (n=25 732) were selected.ResultsA total of 25 732 patients were included in this study. The average mortality and attrition rate were 2.64 and 4.98, respectively, per 100 person-years. Using Cox proportional hazard models, zidovudine-based (AZT-based) regimen versus stavudine-based (D4T-based) regimen had an adjusted HR (AHR) for death of 0.65 (95% CI 0.58 to 0.73); the AHR of tenofovir-based (TDF-based) versus D4T-based regimens was 0.81 (95% CI 0.71 to 0.92), and of lopinavir–ritonavir-based (LPV/r-based) versus D4T-based regimens, 1.19 (95% CI 1.04 to 1.37). AZT-based versus D4T-based regimens had an AHR for dropout of 0.89 (95% CI 0.81 to 0.97); this ratio for TDF-based versus D4T-based regimens was 0.88 (95% CI 0.80 to 0.98), and for LPV/r-based versus D4T-based regimens, 1.42 (95% CI 1.27 to 1.58). AZT-based and TDF-based regimens had a lower risk compared with D4T-based regimens, while LPV/r-based regimens had a higher risk. High gastrointestinal reactions and poor adherence were observed among HIV patients whose initial ART regimen was LPV/r-based.ConclusionsOur study found that the treatment outcomes of initial ART regimens that were AZT-based or TDF-based were significantly better than D4T-based or LPV/r-based regimens. This finding could be related to the higher rates of gastrointestinal reactions and poorer adherence associated with the LPV/r-based regimens compared with other initial ART regimens.

Sign in / Sign up

Export Citation Format

Share Document